DEFERASIROX | N206910 | NOVARTIS PHARMACEUTICALS CORP
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ZYDUS PHARMACEUTICALS (USA) INC. v. NOVARTIS PHARMACEUTICALS CORP. et al 1 patentANDA 211383deferasirox | D.N.J. | 2019-12-10 | Terminated 2020-02-11 | — |
ALEMBIC PHARMACEUTICALS, LTD v. NOVARTIS PHARMACEUTICALS CORP. 2 patentsANDA 211824deferasirox | D.N.J. | 2019-11-27 | Terminated 2020-01-29 | — |
SUN PHARMACEUTICAL INDUSTRIES LIMITED v. NOVARTIS PHARMACEUTICALS CORP. et al 2 patentsANDA 211641deferasirox | D.N.J. | 2019-01-09 | Terminated 2019-04-04 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9283209 | Nov 21, 2034 | — | Yes | Yes | — | — |